TSH Biopharm Corporation Limited Board of Directors resolved to appoint the CFO of the Company. Name, title, and resume of the new position holder:Jung-Liang Kao, Senior Division Director of the Company;Chief Audit Executive of TTY Biopharm Company Limited;Auditor General,CFO, and acting spokesperson of 104 CORPORATION;Senior Director of Audit Department of PwC Taiwan. The newly appointed CFO will take office on April 1, 2024.